Arizona Tech Investors
VC Fund
Mesa, United States
Arizona Tech Investors is an active community of accredited investors who invest in high-potential technology companies based in Arizona. Members invest individually, collectively through single purpose LLCs, and via Sidecar Funds.Candidates for funding apply to a competitive selection process in which the ATI Screening Committee selects 3companies to present at each of the 5 Member Meetings held annually, in January, March, May, September, and October.
- Total investments:
- 66
- Last investment:
- Lead investor:
- 3%
Last updated:
For AI agents: llms.txt
Industries Arizona Tech Investors invests in
Stages Arizona Tech Investors invests in
Countries Arizona Tech Investors invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Harry Curtin
|
|||
Jim Goulka
|
|||
Investment Focus
Industry
- Software 12 (18%)
- Health Care 12 (18%)
- SaaS 11 (17%)
- Medical Device 10 (15%)
- Medical 7 (11%)
Stage
- Seed 25 (38%)
- Angel 17 (26%)
- Series A 8 (12%)
- Pre-Seed 3 (5%)
- Series C 3 (5%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Harry Curtin
Angel Investor
|
Angel Investor | Total investments: 0 | Find email | |
|
Jim Goulka
Managing Director
|
Managing Director | Total investments: 3 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Delta Development
|
Delta manufactures battery operated, medical refrigerators designed to store vaccines and blood products in any climate or environment. Delta is an innovator and manufacturer of ruggedized thermal systems, specializing in military applications. | Series A / Aug 04, 2025 | |
ITC
|
ITC empowers e-commerce businesses with conversational AI shopping assistants that personalize product discovery, boost sales, and provide valuable customer insights. | $200K / Pre-Seed / Aug 01, 2024 | |
Impetus Agriculture
|
Impetus Agriculture focuses on developing multiple topical or transgenic insect control products. Products that are safe, effective, and sustainable. Products that are not subject to the same insect resistance that has developed in current commercial products. | $50K / Angel / Nov 01, 2023 | |
|
Impetus Agriculture
|
Impetus Agriculture focuses on developing multiple topical or transgenic insect control products. Products that are safe, effective, and sustainable. Products that are not subject to the same insect resistance that has developed in current commercial products. | $4M / Convertible Note / Nov 01, 2023 | |
OneForce
|
OneForce is an intelligent software company that develops cognitive technology to specialize in knowledge work automation. Its platform builds software products to fundamentally transform sales, marketing, recruitment, and other domains, and it also helps clients reduce manual tasks and increase productivity. | $810K / Angel / Jul 26, 2023 | |
Anuncia Medical Inc.
|
Anuncia Medical is an early-stage commercial, patient-centric MedTech company with the US cleared and EU-approved, clinically validated, noninvasive, therapeutic device solutions and a robust product pipeline to disrupt the Cerebrospinal Fluid (CSF) Management space. We uniquely address the largest unmet need in CSF Management; the high rate ofventriculoperitoneal (VP) shunt occlusion. VP shunts fail at a rate of 50% within 2 years and 80% within 5 years, contributing to repeat revision brain surgeries (each costing upwards of $40,000). Conceptualized in 2014 in collaboration with Boston Children’s Hospital and spun out of Alcyone Therapeutics in 2018, Anuncia’s patented portfolio of technologies provide peace-of-mind through innovation to improve daily quality of life for the millions of underserved patients with hydrocephalus and other CSF disorders and their families, who suffer from the clinical, economic, and emotional burden of repeat revision brain surgery due to VP shunt occlusions. Anuncia’s core platform has an elegant mechanism of action using a simple finger depression of a soft silicone dome located under the patient’s scalp to produce a noninvasive, retrograde flush of the patient’s own CSF to restore flow through an occluded catheter and prevent emergency surgery.ReFlow’s initial clinical evidence of flow restoration and reduction of symptoms via acute intervention flushing with follow-up up to 3 years, led neurosurgeons to evaluate ReFlow for prophylactic occlusion prevention in their high-risk patients. Ground-breaking clinical data, now out up to 2 years with 100% success, suggest ReFlow is safe for at-home, prophylactic flushing by patients or caregivers to extend shunt life and eliminate revision brain surgery. Supported by these encouraging results, the U.S. Food and Drug Administration (FDA) granted ReFlow Breakthrough Device status in 2021, making it eligible for regulatory and reimbursement advantages. With existing profitable reimbursement, Anuncia plans to launch its next-generation ReFlow Mini product line in Q2 2022 and continue clinical studies to support market adoption and premium reimbursement. With Breakthrough status and strong health economic advantages to improve hospital quality metrics and support New Technology Add-on Payment (NTAP) for rapid market adoption and premium pricing; Anuncia is positioned to be the leader in CSF management and help patients live fuller lives. ReFlow’s unique ability to improve patient access to noninvasive lifesaving therapy at home or in the clinic and to improve clinical outcomes and quality of life, and reduce healthcare costs, earned it an Honorable Mention in the Fast Company 2021 World-Changing Ideas Awards and landed it on MDDI’s The Ultimate List of Private Companies to Watch. | $18K / Angel / Jun 09, 2023 | |
Rivia Health
|
Rivia Health brings ease and efficiency to healthcare patient payments. We work with healthcare provider organizations to complement their revenue cycle operations and get them paid more while doing less.Rivia Health alleviates staff overwhelm by reducing manual tasks related to outstanding patient responsibility. Our communication and paymentplatform integrates with the practice management or RCM system to automate billing workflows like appointment and billing reminders, copay or pre-service payments, and payment plan setup.In addition to saving staff time, Rivia Health also improves financial results by communicating more dynamically to patients about balances across text and email and by making it easier for patients to pay across multiple payment methods with a 3-step, no login required process. | $37.4K / Angel / Apr 21, 2023 | |
AltrixBio
|
AltrixBio is a pharmaceutical company focused on oral drug that replicates the metabolic success of bariatric surgery. | $30K / Angel / Apr 06, 2023 | |
Vartega
|
Vartega is a technology development company specializing in the carbon-fiber-reinforced plastic recycling process. Vartega develops alternative technology, processes, and equipment to provide low-cost carbon fiber for use in mass-market applications.Vartega's patented carbon fiber recycling process scales rapidly to fill a gap in thecomposites supply chain. The company’s carbon fiber is available in semi-continuous, chopped, and milled forms. It is ideally suited for use in thermoplastics, non-wovens, and molding compounds. | $42.5K / Angel / Apr 05, 2023 | |
|
Vartega
|
Vartega is a technology development company specializing in the carbon-fiber-reinforced plastic recycling process. Vartega develops alternative technology, processes, and equipment to provide low-cost carbon fiber for use in mass-market applications.Vartega's patented carbon fiber recycling process scales rapidly to fill a gap in thecomposites supply chain. The company’s carbon fiber is available in semi-continuous, chopped, and milled forms. It is ideally suited for use in thermoplastics, non-wovens, and molding compounds. | $592.5K / Seed / Apr 05, 2023 | |
| See all 66 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Arizona Tech Investors invest in?
Arizona Tech Investors invests primarily in Software, Health Care and SaaS startups, most often at Seed and Angel stage. Most of the 66 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Arizona Tech Investors?
Public channels for Arizona Tech Investors include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Arizona Tech Investors?
The team at Arizona Tech Investors includes Harry Curtin (Angel Investor) and Jim Goulka (Managing Director). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
